Alzheimers Dementia Information. This site uses the clip format. For additional information follow the link in the clip. Fast and easy. Alzheimer's Clips is a companion site of the Alzheimer's Reading Room.
An Alzheimer's drug that attacks abnormal tangles in the brain appeared to slow progression of the disease, British researchers said on Tuesday, but doctors cautioned that the results are early.
The drug, made by private biotechnology company TauRX and called Rember, produced a significant improvement in key measures of thinking and memory in people with moderate Alzheimer's disease, company officials said.
The drug is among the first to attack tangles of tau protein in the brain that are strongly associated with dementia in Alzheimer's disease.
"We've demonstrated for the first time we can halt the disease by a treatment that aims to dissolve the tangles," said Claude Wischik of the University of Aberdeen and chairman of TauRX Therapeutics in Singapore.
The researchers tested 321 patients with mild to moderate Alzheimer's disease at 17 centers in the United Kingdom and Singapore, they told the International Conference on Alzheimer's disease in Chicago.